Principia Biopharma (PRNB) Short Interest Ratio & Short Volume → Crypto Market Preps For Trillions Worth of Inflows! (From Crypto 101 Media) (Ad) Free PRNB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Principia Biopharma Short Interest DataCurrent Short Volume1,580,000 sharesPrevious Short Volume2,000,000 sharesChange Vs. Previous Month-21.00%Dollar Volume Sold Short$157.94 millionShort Interest Ratio / Days to Cover1.1Last Record DateSeptember 15, 2020Outstanding Shares33,209,000 sharesPercentage of Shares Shorted4.76%Today's Trading Volume0 sharesAverage Trading Volume729,676 sharesToday's Volume Vs. Average0% Short Selling Principia Biopharma ? Sign up to receive the latest short interest report for Principia Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPRNB Short Interest Over TimePRNB Days to Cover Over TimePRNB Percentage of Float Shorted Over Time Ad Behind the Markets4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Principia Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20201,580,000 shares $157.94 million -21.0%N/A1.1 $99.96 8/31/20202,000,000 shares $200.02 million -25.9%N/A1.4 $100.01 8/14/20202,700,000 shares $245.00 million -15.4%N/A2 $90.74 7/31/20203,190,000 shares $266.68 million -5.9%N/A6.7 $83.60 7/15/20203,390,000 shares $235.44 million +0.9%N/A7 $69.45 6/30/20203,360,000 shares $189.10 million +45.5%N/A8.9 $56.28 6/15/20202,310,000 shares $140.15 million +6.5%N/A6.6 $60.67 5/29/20202,170,000 shares $138.64 million +0.5%N/A6.5 $63.89 5/15/20202,160,000 shares $138.50 million +8.0%N/A6.7 $64.12 4/30/20202,000,000 shares $126.18 million +2.6%N/A6.1 $63.09 4/15/20201,950,000 shares $113.00 million -12.2%N/A5.7 $57.95 3/31/20202,220,000 shares $131.82 million +25.1%N/A6.8 $59.38 3/13/20201,774,800 shares $91.85 million +15.3%13.9%6.7 $51.75 2/28/20201,540,000 shares $99.42 million -9.4%12.1%4.6 $64.56 2/14/20201,700,000 shares $109.92 million +10.4%N/A5.1 $64.66 1/31/20201,540,000 shares $81.08 million +6.2%N/A4.7 $52.65 1/15/20201,450,000 shares $79.82 million +33.0%N/A4.7 $55.05 12/31/20191,090,000 shares $59.75 million +106.6%N/A3.2 $54.82 8/15/2019770,500 shares $27.86 million -0.6%6.0%5.7 $36.16 PRNB Short Interest - Frequently Asked Questions What is Principia Biopharma's current short interest? Short interest is the volume of Principia Biopharma shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 1,580,000 shares of PRNB short. Learn More on Principia Biopharma's current short interest. What is a good short interest ratio for Principia Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PRNB shares currently have a short interest ratio of 1.0. Learn More on Principia Biopharma's short interest ratio. Is Principia Biopharma's short interest increasing or decreasing? Principia Biopharma saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 1,580,000 shares, a decline of 21.0% from the previous total of 2,000,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Principia Biopharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Principia Biopharma: Amicus Therapeutics, Inc. (10.97%), Xenon Pharmaceuticals Inc. (3.47%), MoonLake Immunotherapeutics (14.83%), Arrowhead Pharmaceuticals, Inc. (7.43%), IDEAYA Biosciences, Inc. (13.55%), Prestige Consumer Healthcare Inc. (3.79%), Bausch Health Companies Inc. (6.67%), Crinetics Pharmaceuticals, Inc. (7.20%), Axsome Therapeutics, Inc. (15.41%), ACADIA Pharmaceuticals Inc. (6.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.24 billion), Aon plc ($3.67 billion), The Clorox Company ($2.89 billion), The Charles Schwab Co. ($2.79 billion), MercadoLibre, Inc. ($2.26 billion), Analog Devices, Inc. ($2.19 billion), Simon Property Group, Inc. ($2.01 billion), The Kroger Co. ($1.94 billion), Moderna, Inc. ($1.89 billion), and International Flavors & Fragrances Inc. ($1.81 billion). View all of the most shorted stocks. What does it mean to sell short Principia Biopharma stock? Short selling PRNB is an investing strategy that aims to generate trading profit from Principia Biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Principia Biopharma? A short squeeze for Principia Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRNB, which in turn drives the price of the stock up even further. How often is Principia Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRNB, twice per month. The most recent reporting period available is September, 15 2020. More Short Interest Resources from MarketBeat Related Companies: FOLD Short Squeeze XENE Short Squeeze MLTX Short Squeeze ARWR Short Squeeze IDYA Short Squeeze PBH Short Squeeze BHC Short Squeeze CRNX Short Squeeze AXSM Short Squeeze ACAD Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRNB) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics